BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4650682)

  • 1. [Effects of combined acute 5-methylpyrazol-3-carbonic acid and insulin loading on the carbohydrate and lipid metabolism parameter in patients with diabetes].
    Zander E; Michaelis D; Wulfert P; Schümann H
    Dtsch Gesundheitsw; 1972 Nov; 27(45):2131-4. PubMed ID: 4650682
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of the lipolysis blocker 5-methylpyrazol-3-carbonic acid (MPC) on changes in carbohydrate and lipid metabolism induced by muscle work in insulin-requiring diabetics].
    Schulz B; Michaelis D; Neumann I; Schäfer H; Wulfert P
    Z Gesamte Inn Med; 1973 Jun; 28(12):345-50. PubMed ID: 4729261
    [No Abstract]   [Full Text] [Related]  

  • 3. Attempts towards oral diabetes therapy by means of inhibition of lipolysis with 5-methylpyrazole-3-carbonic acid.
    Beringer A; Bänder A; Glaninger J; Mayrhofer E; Schnack H
    Horm Metab Res; 1970 Mar; 2(2):81-5. PubMed ID: 5523126
    [No Abstract]   [Full Text] [Related]  

  • 4. [Behavior of carbohydrate and lipid metabolism parameters and of 11-hydroxycorticoids in insulin-needing diabetics under long-term therapy using 5-methylpyrazole-3-carboxylic acid].
    Neumann I; Michaelis D; Bibergeil H; Wulfert P
    Dtsch Gesundheitsw; 1972 May; 27(21):972-6. PubMed ID: 4625279
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of 5-methylpyrazol-3-carbonic acid on the norepinephrine-induced lipolysis in diabetics of labile and stabile metabolic type].
    Michaelis D; Neumann I; Wulfert P; Müller F
    Wien Z Inn Med; 1971; 52(8):409-16. PubMed ID: 5110845
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of insulin and lipolytic blockaders on changes in fat metabolism caused by muscular activity in diabetic patients].
    Schulz B; Michaelis D; Neumann I; Wulfahrt P
    Probl Endokrinol (Mosk); 1974; 20(1):24-8. PubMed ID: 4848587
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dynamic aspects of the correlation between diabetes mellitus and blood lipid disorders].
    Cofaru D; Fekete T
    Stud Cercet Med Interna; 1971; 12(6):545-9. PubMed ID: 5136730
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid-carbohydrate metabolism during operations in patients with diabetes mellitus].
    Davtian NK; Markov IN
    Khirurgiia (Mosk); 1970 Jan; 46(1):109-14. PubMed ID: 5437188
    [No Abstract]   [Full Text] [Related]  

  • 9. [Regadrin treatment of diabetes mellitus].
    Hohlfeld R; Neugebauer A; Haaser B; Marek H; Reuter W
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:154-6. PubMed ID: 4734038
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in blood sugar and reduced insulin sensitivity].
    Razzoli G
    Minerva Cardioangiol; 1977 Apr; 25(4):IX-XII. PubMed ID: 887203
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of physical exercise on the glyco-lipid effect in normal and diabetic subjects].
    Ferlito S; Di Mauro C; Costa A; Branca S; Raudino M
    G Clin Med; 1980 Oct; 61(10):728-39. PubMed ID: 7016646
    [No Abstract]   [Full Text] [Related]  

  • 12. [Muscle work and diabetes mellitus. II. Influence of subliminal insulin doses on the carbohydrate and lipid metabolism under acute work-load].
    Schulz B; Michaelis D; Schäfer H; Jung V
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(3):201-7. PubMed ID: 5516692
    [No Abstract]   [Full Text] [Related]  

  • 13. [Some aspects of the relations between disorders of carbohydrate and lipid metabolism in simple obesity].
    Gligore V; Lucaciu O; Hîncu N; Ureche A
    Med Interna (Bucur); 1970 Jan; 22(1):29-38. PubMed ID: 5527971
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of intravenous administration of N 1-n-butylbiguanide on carbohydrate and lipid metabolism in diabetics].
    Michaelis D; Lippmann HG; Köhler E
    Dtsch Gesundheitsw; 1970 May; 25(19):870-4. PubMed ID: 5523783
    [No Abstract]   [Full Text] [Related]  

  • 15. [Disorders of carbohydrate and lipid metabolism in the early stages of essential hypertension as the pathogenetic factors of arteriosclerosis risk].
    Baumann R
    Vestn Akad Med Nauk SSSR; 1977; (5):76-87. PubMed ID: 888576
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of lipolysis and its inhibition on the diabetic metabolic disorders and cholesterol levels].
    Beringer A; Bänder A; Glaninger J; Mayerhofer E
    Wien Z Inn Med; 1971; 52(1):1-14. PubMed ID: 5540814
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diabetes and exercise].
    Koivisto V
    Duodecim; 1981; 97(12):848-56. PubMed ID: 7028447
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipid and carbohydrate metabolism in diabetics with hypercholesteremia during long-term treatment with beta-pyridylcarbinol].
    Wandrey H; Geser CA; Zöllner N
    Med Klin; 1970 Apr; 65(14):668-76. PubMed ID: 5507801
    [No Abstract]   [Full Text] [Related]  

  • 19. [Various parameters of the lipid metabolism in diabetes mellitus].
    Pfeifer U; Linke E
    Z Gesamte Inn Med; 1972 Feb; 27(3):95-100. PubMed ID: 5024246
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of gluco-lipid metabolism in relation to insulin and growth hormone in obese patients].
    Durán García S; Marañón Cabello A; Romero Bobillo E; Zurro Hernández J; Gómez López A; Romero E
    Rev Clin Esp; 1973 Nov; 131(3):205-12. PubMed ID: 4769038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.